Literature DB >> 1714013

Nicorandil-induced vasorelaxation: functional evidence for K+ channel-dependent and cyclic GMP-dependent components in a single vascular preparation.

K D Meisheri1, L A Cipkus-Dubray, J M Hosner, S A Khan.   

Abstract

Using a series of functional criteria, we wished to evaluate the K+ conductance mechanism and the cyclic GMP mechanism implicated in the actions of nicorandil (NIC) as a vasodilator. In rabbit isolated superior mesenteric artery, NIC exhibited two relaxation dose-response curves (DRCs): one with a lower IC50 of 4.8 x 10(-6) M for norepinephrine (NE 5 microM) contraction, and another with a higher IC50 of 1.4 x 10(-4) M for 80 mM K+ contraction. K+ channel blockers (TEA 1-10 mM), Ba2+ (0.1-0.5 mM), glyburide (1 microM), and increased [K+]ex (20 mM), all caused significant attenuations in the ability of NIC to relax NE contraction, but did not influence the ability of NIC to relax high-K+ contraction. Pretreatment with 5 microM methylene blue, a guanylate cyclase inhibitor, produced a pronounced inhibition of nitroglycerine (NTG) relaxation, but only a marginal inhibitory effect on the NIC relaxation DRC for NE contraction. Functional studies demonstrated that the inhibitory effect of NIC on NE-sensitive intracellular Ca2+ release occurred in the same concentration range as that required for relaxation of 80 mM K+ contractions (10(-5)-10(-3) M). Furthermore, NIC also caused increases in cellular cyclic GMP levels at this higher concentration range. Finally, NIC relaxation of NE contraction was not prone either to self-tolerance (30 mM NIC preexposure) or cross-tolerance (0.55 mM NTG preexposure) development. In contrast, a modest but significant degree of self-tolerance to NIC could be demonstrated under high-K+ contraction condition. These studies thus show the existence of both cellular mechanisms for NIC in the same vascular preparation and further show that these two mechanistic components are separate and independent. The K+ channel-dependent component occurs at lower concentrations, is blocked by K+ channel blockers, is not inhibited by methylene blue, is not associated with increases in cyclic GMP, and is not prone to tolerance development. In this, NIC resembles other K+ channel openers. The cyclic GMP-dependent component is evident at relatively higher concentrations, is associated with inhibition of [Ca2+]i release, is associated with increases in cyclic GMP levels, and is prone to tolerance development. In this, NIC resembles other nitrovasodilators. A combination of these characteristics of the actions of NIC may contribute to the differences in the acute versus chronic hemodynamic profile of NIC.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1714013

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  13 in total

1.  Effects of N-acetylcysteine on nitroglycerin-induced relaxation and protein phosphorylation of porcine coronary arteries.

Authors:  Y Tate; K Kawasaki; S Ishibashi; U Ikeda; K Shimada
Journal:  Heart Vessels       Date:  1998       Impact factor: 2.037

2.  Contribution of cyclic GMP formation to KRN2391-induced relaxation in coronary artery of the pig.

Authors:  Y Jinno; H Kasai; H Ohta; K Nishikori; H Fukushima; N Ogawa
Journal:  Br J Pharmacol       Date:  1992-08       Impact factor: 8.739

3.  Characterization of furoxans as a new class of tolerance-resistant nitrovasodilators.

Authors:  M Hecker; W Vorhoff; A T Bara; P I Mordvintcev; R Busse
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1995-04       Impact factor: 3.000

4.  [Nicorandil: acute hemodynamic effects of 2 different oral doses of a potassium channel opener in patients with coronary heart disease].

Authors:  C Bickel; H J Rupprecht; A Tyrtania; J Rörig; J Meyer
Journal:  Med Klin (Munich)       Date:  1999-02-15

5.  Effects of nicorandil as compared to mixtures of sodium nitroprusside and levcromakalim in isolated rat aorta.

Authors:  A L Cogolludo; F Pérez-Vizcaíno; S Fajardo; M Ibarra; J Tamargo
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

6.  Analysis of relaxation and repolarization mechanisms of nicorandil in rat mesenteric artery.

Authors:  T Fujiwara; J A Angus
Journal:  Br J Pharmacol       Date:  1996-12       Impact factor: 8.739

7.  NO hyperpolarizes pulmonary artery smooth muscle cells and decreases the intracellular Ca2+ concentration by activating voltage-gated K+ channels.

Authors:  X J Yuan; M L Tod; L J Rubin; M P Blaustein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

8.  Mechanism of the vasodilatory action of nicorandil on coronary circulation in dogs.

Authors:  I Nakae; L Quan; K Hashimoto; Y Sugimoto; T Tsutamoto; M Kinoshita
Journal:  Cardiovasc Drugs Ther       Date:  1994-02       Impact factor: 3.727

9.  Nicorandil protects cardiac mitochondria against permeability transition induced by ischemia-reperfusion.

Authors:  Raquel S Carreira; Pedro Monteiro; Alicia J Kowaltowski; Lino M Gonçalves; Luís A Providência
Journal:  J Bioenerg Biomembr       Date:  2008-04-16       Impact factor: 2.945

10.  Nicorandil stimulates a Na⁺/Ca²⁺ exchanger by activating guanylate cyclase in guinea pig cardiac myocytes.

Authors:  Jiazhang Wei; Yasuhide Watanabe; Kazuhiko Takeuchi; Kanna Yamashita; Miyuki Tashiro; Satomi Kita; Takahiro Iwamoto; Hiroshi Watanabe; Junko Kimura
Journal:  Pflugers Arch       Date:  2015-12-03       Impact factor: 3.657

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.